Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays

Cancer Genetics and Cytogenetics

Volumn 182, Issue 2, 2008, Pages 84-94

  Rassekh, Shahrad Rod ^a   Chan, Suzanne ^b   Harvard, Chansonette ^b   Dix, David ^a   Qiao, Ying ^b   Rajcan Separovic, Evica ^b  

^a Division of Pediatric Hematology/Oncology   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 1; CHROMOSOME 11Q; CHROMOSOME 16; CHROMOSOME 2Q; CHROMOSOME 7Q; CHROMOSOME G BAND; CHROMOSOME REARRANGEMENT; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HUMAN; NEPHROBLASTOMA; PATHOGENESIS; PRIORITY JOURNAL;

CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPING; KIDNEY NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; WILMS TUMOR;

EID: 41749111811     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.12.015     Document Type: Article

References (44)

1. Stiller C.A., and Parkin D.M. International variations in the incidence of childhood renal tumours. Br J Cancer 62 (1990) 1026-1030
2. Breslow N.E., Norris R.N., Norkool P.A., Kang T., Beckwith J.B., Perlman E.J., Ritchey M.L., Green D.M., Nichols K.E., and National Wilms Tumor Study Group. Characteristics and outcomes of children with the Wilms tumor-aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol 21 (2003) 4579-4585
3. Hentrich M.U., Meister P., Brack N.G., Lutz L.L., and Hartenstein R.C. Adult Wilms' tumor: report of two cases and review of the literature. Cancer 75 (1995) 545-551
4. Green D.M. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol 22 (2004) 1366-1372
5. Steenman M., Westerveld A., and Mannens M. Genetics of Beckwith-Wiedemann syndrome-associated tumors: common genetic pathways. Genes Chromosomes Cancer 28 (2000) 1-13
6. McTaggart S.J., Algar E., Chow C.W., Powell H.R., and Jones C.L. Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol 16 (2001) 335-339
7. Porteus M.H., Narkool P., Neuberg D., Guthrie K., Breslow N., Green D.M., Diller L., and National Wilms Tumor Study Group. Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 18 (2000) 2026-2031
8. Höglund M., Gisselsson D., Hansen G.B., and Mitelman F. Wilms tumors develop through two distinct karyotypic pathways. Cancer Genet Cytogenet 150 (2004) 9-15
9. Ghanem M.A., van Steenbrugge G.J., Nijman R.J.M., and van der Kwast T.H. Prognostic markers in nephroblastoma (Wilms' tumor). Urology 65 (2005) 1047-1054
10. Bown N., Cotterill S.J., Roberts P., Griffiths M., Larkins S., Hibbert S., Middleton H., Kelsey A., Tritton D., Mitchell C., U.K. Cancer Cytogenetics Group, and U.K. Children's Cancer Study Group. Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 38 (2002) 11-21
11. Grundy P.E., Telzerow P.E., Breslow N., Moksness J., Huff V., and Paterson M.C. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54 (1994) 2331-2333
12. Natrajan R., Williams R.D., Hing S.N., Mackay A., Reis-Filho J.S., Fenwick K., Iravani M., Valgeirsson H., Grigoriadis A., Langford C.F., Dovey O., Gregory S.G., Weber B.L., Ashworth A., Grundy P.E., Pritchard-Jones K., and Jones C. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol 210 (2006) 49-58
13. Grundy P.E., Breslow N.E., Li S., Perlman E., Beckwith J.B., Ritchey M.L., Shamberger R.C., Haase G.M., D'Angio G.J., Donaldson M., Coppes M.J., Malogolowkin M., Shearer P., Thomas P.R.M., Macklis R., Tomlinson G., Huff V., Green D.M., Grundy P.E., Breslow N.E., Li S., Perlman E., Beckwith J.B., Ritchey M.L., Shamberger R.C., Haase G.M., D'Angio G.J., Donaldson M., Coppes M.J., Malogolowkin M., Shearer P., Thomas P.R.M., Macklis R., Tomlinson G., Huff V., and Green D.M. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23 (2005) 7312-7321
14. Knight S.J.L., and Regan R. Idiopathic learning disability and genome imbalance. Cytogenet Genome Res 115 (2006) 215
15. Menten B., Maas N., Thienpont B., Buysse K., Vandesompele J., Melotte C., de Ravel T., Van Vooren S., Balikova I., Backx L., Janssens S., De Paepe A., De Moor B., Moreau Y., Marynen P., Fryns J.P., Mortier G., Devriendt K., Speleman F., and Vermeesch J.R. Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet 43 (2006) 625-633
16. Davies J.J., Wilson I.M., and Lam W.L. Array CGH technologies and their applications to cancer genomes. [Erratum in: Chromosome Res 2005;13:423]. Chromosome Res 13 (2005) 237-248
17. Natrajan R., Williams R.D., Hing S.N., Mackay A., Reis-Filho J.S., Fenwick K., Iravani M., Valgeirsson H., Grigoriadis A., Langford C.F., Dovey O., Gregory S.G., Weber B.L., Ashworth A., Grundy P.E., Pritchard-Jones K., and Jones C. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. J Pathol 210 (2006) 49-58
18. Natrajan R., Little S.E., Sodha N., Reis-Filho J.S., Mackay A., Fenwick K., Ashworth A., Perlman E.J., Dome J.S., Grundy P.E., Pritchard-Jones K., and Jones C. Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour. J Pathol 211 (2007) 52-59
19. Schaub R., Burger A., Bausch D., Niggli F.K., Schäfer B.W., and Betts D.R. Array comparative genomic hybridization reveals unbalanced gain of the MYCN region in Wilms tumors. Cancer Genet Cytogenet 172 (2007) 61-65
20. Benetkiewicz M., de Ståhl T.D., Gördör A., Pfeifer S., Wittmann S., Gessler M., and Dumanski J.P. Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array. Int J Cancer 119 (2006) 571-578
21. Goldstein M., Rennert H., Bar-Shira A., Burstein Y., Yaron Y., and Orr-Urtreger A. Combined cytogenetic and array-based comparative genomic hybridization analyses of Wilms tumors: amplification and overexpression of the multidrug resistance associated protein 1 gene (MRP1) in a metachronous tumor. Cancer Genet Cytogenet 141 (2003) 120-127
22. Tyybäkinoja A., Elonen E., Piippo K., Porkka K., and Knuutila S. Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia 21 (2007) 571-574
23. Gow K.W., and Murphy J.J. Cytogenetic and histologic findings in Wilms' tumor. J Pediatr Surg 37 (2002) 823-827
24. Kullendorff C.M., Soller M., Wiebe T., and Mertens F. Cytogenetic findings and clinical course in a consecutive series of Wilms tumors. Cancer Genet Cytogenet 140 (2003) 82-87
25. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
26. Rajcan-Separovic E., Maguire J., Loukianova T., Nisha M., and Kalousek D. Loss of 1p and 7p in radiation-induced meningiomas identified by comparative genomic hybridization. Cancer Genet Cytogenet 144 (2003) 6-11
27. Tyson C., Harvard C., Locker R., Friedman J.M., Langlois S., Lewis M.E.S., Van Allen M., Somerville M., Arbour L., Clarke L., McGilivray B., Yong S.L., Siegel-Bartel J., and Rajcan-Separovic E. Submicroscopic deletions and duplications in individuals with intellectual disability detected by array-CGH. Am J Med Genet A 139 (2005) 173-185
28. Lapierre J.M., and Tachdjian G. Detection of chromosomal abnormalities by comparative genomic hybridization. Curr Opin Obstet Gynecol 17 (2005) 171-177
29. Schoumans J., Ruivenkamp C., Holmberg E., Kyllerman M., Anderlid B.-M., and Nordenskjöld M. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH). J Med Genetics 42 (2005) 699-705
30. Rajcan-Separovic E., Hendson G., Tang S., Seto E., Thomson T., Phillips D., and Kalousek D. Interphase fluorescence in situ hybridization and DNA flow cytometry analysis of medulloblastomas with a normal karyotype. Cancer Genet Cytogenet 133 (2002) 94-97
31. Ballif B.C., Rorem E.A., Sundin K., Lincicum M., Gaskin S., Coppinger J., Kashork C.D., Shaffer L.G., and Bejjani B.A. Detection of low-level mosaicism by array CGH in routine diagnostic specimens. Am J Med Genet A 140 (2006) 2757-2767
32. Hosomi Y., Gemma A., Hosoya Y., Nara M., Okano T., Takenaka K., Yoshimura A., Koizumi K., Shimizu K., and Kudoh S. Somatic mutation of the caspase-5 gene in human lung cancer. Int J Mol Med 12 (2003) 443-446
33. Scott S., Kimura T., Ichinohasama R., Bergen S., Magliocco A., Reimer C., Kerviche A., Sheridan D., and DeCoteau J.F. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Leuk Res 27 (2003) 23-34
34. Radice P., Perotti D., De Benedetti V., Mondini P., Radice M.T., Pilotti S., Luksch R., Fossati Bellani F., and Pierotti M.A. Allelotyping in Wilms tumors identifies a putative third tumor suppressor gene on chromosome 11. Genomics 27 (1995) 497-501
35. Barbini L., Gonzalez R., Dominguez F., and Vega F. Apoptotic and proliferating hepatocytes differ in prothymosin alpha expression and cell localization. Mol Cell Biochem 291 (2006) 83-91
36. Saxena A., Rorie C.J., Dimitrova D., Daniely Y., and Borowiec J.A. Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene 25 (2006) 7274-7288
37. Uejima H., Shinohara T., Nakayama Y., Kugoh H., and Oshimura M. Mapping a novel cellular-senescence gene to human chromosome 2q37 by irradiation microcell-mediated chromosome transfer. Mol Carcinogen 22 (1998) 34-45
38. Casas K.A., Mononen T.K., Mikail C.N., Hassed S.J., Li S., Mulvihill J.J., Lin H.J., and Falk R.E. Chromosome 2q terminal deletion: report of 6 new patients and review of phenotype-breakpoint correlations in 66 individuals. Am J Med Genet A 130 (2004) 331-339
39. Patton M.A., and Afzal A.R. Robinow syndrome. J Med Genet 39 (2002) 305-310
40. Wiens L., Strickland D.K., Sniffen B., and Warady B.A. Robinow syndrome: report of two patients with cystic kidney disease. Clin Genet 37 (1990) 481-484
41. Kondo T., Oue N., Yoshida K., Mitani Y., Naka K., Nakayama H., and Yasui W. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 64 (2004) 523-529
42. Lestou V.S., Desilets V., Lomax B.L., Barrett I.J., Wilson R.D., Langlois S., and Kalousek D.K. Comparative genomic hybridization: a new approach to screening for intrauterine complete or mosaic aneuploidy. Am J Med Genet 92 (2000) 281-284
43. Barrett I.J., Lomax B.L., Loukianova T., Tang S.S., Lestou V.S., and Kalousek D.K. Comparative genomic hybridization: a new tool for reproductive pathology. Arch Pathol Lab Med 125 (2001) 81-84
44. Cheung S.W., Shaw C.A., Scott D.A., Patel A., Sahoo T., Bacino C.A., Pursley A., Li J., Erickson R., Gropman A.L., Miller D.T., Seashore M.R., Summers A.M., Stankiewicz P., Chinault A.C., Lupski J.R., Beaudet A.L., and Sutton V.R. Microarray-based CGH detects chromosomal mosaicism not revealed by conventional cytogenetics. Am J Med Genet A 143 (2007) 1679-1686